IMPRESSION Randomized Trial: Past the Halfway Mark and Progressing Rapidly

The sirolimus coated balloon thus seems to be a promising option as the Magic Touch – AVF was granted breakthrough device designation by FDA in 2019, and the IMPRESSION RCT will provide the much-needed data.